Global Anti-Smoking Products Market Size, Status and Forecast 2020-2026

May 2020 | 90 pages | ID: GA20B3A2ABDBEN
QYResearch

Abstracts

This report focuses on the global Anti-Smoking Products status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Anti-Smoking Products development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Pfizer
• Cipla
• Novartis International
• GSK
• Takeda pharmaceutical
• McNeil AB
• Revolymer plc
• Imperial Tobacco
• Elder Pharma
• NJOY
• VMR products
• Lorillard
• VaporCorp

Market segment by Type, the product can be split into

• Nicotine Replacement Therapy
• Drug therapy
• E-cigarettes

Market segment by Application, split into

• Smokers aged 18–24
• Smokers aged 25–44
• Smokers aged 45–64
• Smokers aged 65 years or older

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Anti-Smoking Products status, future forecast, growth opportunity, key market and key players.
• To present the Anti-Smoking Products development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Anti-Smoking Products are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Anti-Smoking Products Revenue
1.4 Market Analysis by Type
  1.4.1 Global Anti-Smoking Products Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Nicotine Replacement Therapy
  1.4.3 Drug therapy
  1.4.4 E-cigarettes
1.5 Market by Application
  1.5.1 Global Anti-Smoking Products Market Share by Application: 2020 VS 2026
  1.5.2 Smokers aged 18–24
  1.5.3 Smokers aged 25–44
  1.5.4 Smokers aged 45–64
  1.5.5 Smokers aged 65 years or older
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Anti-Smoking Products Market Perspective (2015-2026)
2.2 Anti-Smoking Products Growth Trends by Regions
  2.2.1 Anti-Smoking Products Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Anti-Smoking Products Historic Market Share by Regions (2015-2020)
  2.2.3 Anti-Smoking Products Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Anti-Smoking Products Market Growth Strategy
  2.3.6 Primary Interviews with Key Anti-Smoking Products Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Anti-Smoking Products Players by Market Size
  3.1.1 Global Top Anti-Smoking Products Players by Revenue (2015-2020)
  3.1.2 Global Anti-Smoking Products Revenue Market Share by Players (2015-2020)
  3.1.3 Global Anti-Smoking Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Anti-Smoking Products Market Concentration Ratio
  3.2.1 Global Anti-Smoking Products Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Anti-Smoking Products Revenue in 2019
3.3 Anti-Smoking Products Key Players Head office and Area Served
3.4 Key Players Anti-Smoking Products Product Solution and Service
3.5 Date of Enter into Anti-Smoking Products Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Anti-Smoking Products Historic Market Size by Type (2015-2020)
4.2 Global Anti-Smoking Products Forecasted Market Size by Type (2021-2026)

5 ANTI-SMOKING PRODUCTS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Anti-Smoking Products Market Size by Application (2015-2020)
5.2 Global Anti-Smoking Products Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Anti-Smoking Products Market Size (2015-2020)
6.2 Anti-Smoking Products Key Players in North America (2019-2020)
6.3 North America Anti-Smoking Products Market Size by Type (2015-2020)
6.4 North America Anti-Smoking Products Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Anti-Smoking Products Market Size (2015-2020)
7.2 Anti-Smoking Products Key Players in Europe (2019-2020)
7.3 Europe Anti-Smoking Products Market Size by Type (2015-2020)
7.4 Europe Anti-Smoking Products Market Size by Application (2015-2020)

8 CHINA

8.1 China Anti-Smoking Products Market Size (2015-2020)
8.2 Anti-Smoking Products Key Players in China (2019-2020)
8.3 China Anti-Smoking Products Market Size by Type (2015-2020)
8.4 China Anti-Smoking Products Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Anti-Smoking Products Market Size (2015-2020)
9.2 Anti-Smoking Products Key Players in Japan (2019-2020)
9.3 Japan Anti-Smoking Products Market Size by Type (2015-2020)
9.4 Japan Anti-Smoking Products Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Anti-Smoking Products Market Size (2015-2020)
10.2 Anti-Smoking Products Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Anti-Smoking Products Market Size by Type (2015-2020)
10.4 Southeast Asia Anti-Smoking Products Market Size by Application (2015-2020)

11 INDIA

11.1 India Anti-Smoking Products Market Size (2015-2020)
11.2 Anti-Smoking Products Key Players in India (2019-2020)
11.3 India Anti-Smoking Products Market Size by Type (2015-2020)
11.4 India Anti-Smoking Products Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Anti-Smoking Products Market Size (2015-2020)
12.2 Anti-Smoking Products Key Players in Central & South America (2019-2020)
12.3 Central & South America Anti-Smoking Products Market Size by Type (2015-2020)
12.4 Central & South America Anti-Smoking Products Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Pfizer
  13.1.1 Pfizer Company Details
  13.1.2 Pfizer Business Overview and Its Total Revenue
  13.1.3 Pfizer Anti-Smoking Products Introduction
  13.1.4 Pfizer Revenue in Anti-Smoking Products Business (2015-2020))
  13.1.5 Pfizer Recent Development
13.2 Cipla
  13.2.1 Cipla Company Details
  13.2.2 Cipla Business Overview and Its Total Revenue
  13.2.3 Cipla Anti-Smoking Products Introduction
  13.2.4 Cipla Revenue in Anti-Smoking Products Business (2015-2020)
  13.2.5 Cipla Recent Development
13.3 Novartis International
  13.3.1 Novartis International Company Details
  13.3.2 Novartis International Business Overview and Its Total Revenue
  13.3.3 Novartis International Anti-Smoking Products Introduction
  13.3.4 Novartis International Revenue in Anti-Smoking Products Business (2015-2020)
  13.3.5 Novartis International Recent Development
13.4 GSK
  13.4.1 GSK Company Details
  13.4.2 GSK Business Overview and Its Total Revenue
  13.4.3 GSK Anti-Smoking Products Introduction
  13.4.4 GSK Revenue in Anti-Smoking Products Business (2015-2020)
  13.4.5 GSK Recent Development
13.5 Takeda pharmaceutical
  13.5.1 Takeda pharmaceutical Company Details
  13.5.2 Takeda pharmaceutical Business Overview and Its Total Revenue
  13.5.3 Takeda pharmaceutical Anti-Smoking Products Introduction
  13.5.4 Takeda pharmaceutical Revenue in Anti-Smoking Products Business (2015-2020)
  13.5.5 Takeda pharmaceutical Recent Development
13.6 McNeil AB
  13.6.1 McNeil AB Company Details
  13.6.2 McNeil AB Business Overview and Its Total Revenue
  13.6.3 McNeil AB Anti-Smoking Products Introduction
  13.6.4 McNeil AB Revenue in Anti-Smoking Products Business (2015-2020)
  13.6.5 McNeil AB Recent Development
13.7 Revolymer plc
  13.7.1 Revolymer plc Company Details
  13.7.2 Revolymer plc Business Overview and Its Total Revenue
  13.7.3 Revolymer plc Anti-Smoking Products Introduction
  13.7.4 Revolymer plc Revenue in Anti-Smoking Products Business (2015-2020)
  13.7.5 Revolymer plc Recent Development
13.8 Imperial Tobacco
  13.8.1 Imperial Tobacco Company Details
  13.8.2 Imperial Tobacco Business Overview and Its Total Revenue
  13.8.3 Imperial Tobacco Anti-Smoking Products Introduction
  13.8.4 Imperial Tobacco Revenue in Anti-Smoking Products Business (2015-2020)
  13.8.5 Imperial Tobacco Recent Development
13.9 Elder Pharma
  13.9.1 Elder Pharma Company Details
  13.9.2 Elder Pharma Business Overview and Its Total Revenue
  13.9.3 Elder Pharma Anti-Smoking Products Introduction
  13.9.4 Elder Pharma Revenue in Anti-Smoking Products Business (2015-2020)
  13.9.5 Elder Pharma Recent Development
13.10 NJOY
  13.10.1 NJOY Company Details
  13.10.2 NJOY Business Overview and Its Total Revenue
  13.10.3 NJOY Anti-Smoking Products Introduction
  13.10.4 NJOY Revenue in Anti-Smoking Products Business (2015-2020)
  13.10.5 NJOY Recent Development
13.11 VMR products
  10.11.1 VMR products Company Details
  10.11.2 VMR products Business Overview and Its Total Revenue
  10.11.3 VMR products Anti-Smoking Products Introduction
  10.11.4 VMR products Revenue in Anti-Smoking Products Business (2015-2020)
  10.11.5 VMR products Recent Development
13.12 Lorillard
  10.12.1 Lorillard Company Details
  10.12.2 Lorillard Business Overview and Its Total Revenue
  10.12.3 Lorillard Anti-Smoking Products Introduction
  10.12.4 Lorillard Revenue in Anti-Smoking Products Business (2015-2020)
  10.12.5 Lorillard Recent Development
13.13 VaporCorp
  10.13.1 VaporCorp Company Details
  10.13.2 VaporCorp Business Overview and Its Total Revenue
  10.13.3 VaporCorp Anti-Smoking Products Introduction
  10.13.4 VaporCorp Revenue in Anti-Smoking Products Business (2015-2020)
  10.13.5 VaporCorp Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Anti-Smoking Products Key Market Segments
Table 2. Key Players Covered: Ranking by Anti-Smoking Products Revenue
Table 3. Ranking of Global Top Anti-Smoking Products Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Anti-Smoking Products Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Nicotine Replacement Therapy
Table 6. Key Players of Drug therapy
Table 7. Key Players of E-cigarettes
Table 8. Global Anti-Smoking Products Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Anti-Smoking Products Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Anti-Smoking Products Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Anti-Smoking Products Market Share by Regions (2015-2020)
Table 12. Global Anti-Smoking Products Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Anti-Smoking Products Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Anti-Smoking Products Market Growth Strategy
Table 18. Main Points Interviewed from Key Anti-Smoking Products Players
Table 19. Global Anti-Smoking Products Revenue by Players (2015-2020) (Million US$)
Table 20. Global Anti-Smoking Products Market Share by Players (2015-2020)
Table 21. Global Top Anti-Smoking Products Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Smoking Products as of 2019)
Table 22. Global Anti-Smoking Products by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Anti-Smoking Products Product Solution and Service
Table 25. Date of Enter into Anti-Smoking Products Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Anti-Smoking Products Market Size by Type (2015-2020) (Million US$)
Table 28. Global Anti-Smoking Products Market Size Share by Type (2015-2020)
Table 29. Global Anti-Smoking Products Revenue Market Share by Type (2021-2026)
Table 30. Global Anti-Smoking Products Market Size Share by Application (2015-2020)
Table 31. Global Anti-Smoking Products Market Size by Application (2015-2020) (Million US$)
Table 32. Global Anti-Smoking Products Market Size Share by Application (2021-2026)
Table 33. North America Key Players Anti-Smoking Products Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Anti-Smoking Products Market Share (2019-2020)
Table 35. North America Anti-Smoking Products Market Size by Type (2015-2020) (Million US$)
Table 36. North America Anti-Smoking Products Market Share by Type (2015-2020)
Table 37. North America Anti-Smoking Products Market Size by Application (2015-2020) (Million US$)
Table 38. North America Anti-Smoking Products Market Share by Application (2015-2020)
Table 39. Europe Key Players Anti-Smoking Products Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Anti-Smoking Products Market Share (2019-2020)
Table 41. Europe Anti-Smoking Products Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Anti-Smoking Products Market Share by Type (2015-2020)
Table 43. Europe Anti-Smoking Products Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Anti-Smoking Products Market Share by Application (2015-2020)
Table 45. China Key Players Anti-Smoking Products Revenue (2019-2020) (Million US$)
Table 46. China Key Players Anti-Smoking Products Market Share (2019-2020)
Table 47. China Anti-Smoking Products Market Size by Type (2015-2020) (Million US$)
Table 48. China Anti-Smoking Products Market Share by Type (2015-2020)
Table 49. China Anti-Smoking Products Market Size by Application (2015-2020) (Million US$)
Table 50. China Anti-Smoking Products Market Share by Application (2015-2020)
Table 51. Japan Key Players Anti-Smoking Products Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Anti-Smoking Products Market Share (2019-2020)
Table 53. Japan Anti-Smoking Products Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Anti-Smoking Products Market Share by Type (2015-2020)
Table 55. Japan Anti-Smoking Products Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Anti-Smoking Products Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Anti-Smoking Products Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Anti-Smoking Products Market Share (2019-2020)
Table 59. Southeast Asia Anti-Smoking Products Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Anti-Smoking Products Market Share by Type (2015-2020)
Table 61. Southeast Asia Anti-Smoking Products Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Anti-Smoking Products Market Share by Application (2015-2020)
Table 63. India Key Players Anti-Smoking Products Revenue (2019-2020) (Million US$)
Table 64. India Key Players Anti-Smoking Products Market Share (2019-2020)
Table 65. India Anti-Smoking Products Market Size by Type (2015-2020) (Million US$)
Table 66. India Anti-Smoking Products Market Share by Type (2015-2020)
Table 67. India Anti-Smoking Products Market Size by Application (2015-2020) (Million US$)
Table 68. India Anti-Smoking Products Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Anti-Smoking Products Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Anti-Smoking Products Market Share (2019-2020)
Table 71. Central & South America Anti-Smoking Products Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Anti-Smoking Products Market Share by Type (2015-2020)
Table 73. Central & South America Anti-Smoking Products Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Anti-Smoking Products Market Share by Application (2015-2020)
Table 75. Pfizer Company Details
Table 76. Pfizer Business Overview
Table 77. Pfizer Product
Table 78. Pfizer Revenue in Anti-Smoking Products Business (2015-2020) (Million US$)
Table 79. Pfizer Recent Development
Table 80. Cipla Company Details
Table 81. Cipla Business Overview
Table 82. Cipla Product
Table 83. Cipla Revenue in Anti-Smoking Products Business (2015-2020) (Million US$)
Table 84. Cipla Recent Development
Table 85. Novartis International Company Details
Table 86. Novartis International Business Overview
Table 87. Novartis International Product
Table 88. Novartis International Revenue in Anti-Smoking Products Business (2015-2020) (Million US$)
Table 89. Novartis International Recent Development
Table 90. GSK Company Details
Table 91. GSK Business Overview
Table 92. GSK Product
Table 93. GSK Revenue in Anti-Smoking Products Business (2015-2020) (Million US$)
Table 94. GSK Recent Development
Table 95. Takeda pharmaceutical Company Details
Table 96. Takeda pharmaceutical Business Overview
Table 97. Takeda pharmaceutical Product
Table 98. Takeda pharmaceutical Revenue in Anti-Smoking Products Business (2015-2020) (Million US$)
Table 99. Takeda pharmaceutical Recent Development
Table 100. McNeil AB Company Details
Table 101. McNeil AB Business Overview
Table 102. McNeil AB Product
Table 103. McNeil AB Revenue in Anti-Smoking Products Business (2015-2020) (Million US$)
Table 104. McNeil AB Recent Development
Table 105. Revolymer plc Company Details
Table 106. Revolymer plc Business Overview
Table 107. Revolymer plc Product
Table 108. Revolymer plc Revenue in Anti-Smoking Products Business (2015-2020) (Million US$)
Table 109. Revolymer plc Recent Development
Table 110. Imperial Tobacco Business Overview
Table 111. Imperial Tobacco Product
Table 112. Imperial Tobacco Company Details
Table 113. Imperial Tobacco Revenue in Anti-Smoking Products Business (2015-2020) (Million US$)
Table 114. Imperial Tobacco Recent Development
Table 115. Elder Pharma Company Details
Table 116. Elder Pharma Business Overview
Table 117. Elder Pharma Product
Table 118. Elder Pharma Revenue in Anti-Smoking Products Business (2015-2020) (Million US$)
Table 119. Elder Pharma Recent Development
Table 120. NJOY Company Details
Table 121. NJOY Business Overview
Table 122. NJOY Product
Table 123. NJOY Revenue in Anti-Smoking Products Business (2015-2020) (Million US$)
Table 124. NJOY Recent Development
Table 125. VMR products Company Details
Table 126. VMR products Business Overview
Table 127. VMR products Product
Table 128. VMR products Revenue in Anti-Smoking Products Business (2015-2020) (Million US$)
Table 129. VMR products Recent Development
Table 130. Lorillard Company Details
Table 131. Lorillard Business Overview
Table 132. Lorillard Product
Table 133. Lorillard Revenue in Anti-Smoking Products Business (2015-2020) (Million US$)
Table 134. Lorillard Recent Development
Table 135. VaporCorp Company Details
Table 136. VaporCorp Business Overview
Table 137. VaporCorp Product
Table 138. VaporCorp Revenue in Anti-Smoking Products Business (2015-2020) (Million US$)
Table 139. VaporCorp Recent Development
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Anti-Smoking Products Market Share by Type: 2020 VS 2026
Figure 2. Nicotine Replacement Therapy Features
Figure 3. Drug therapy Features
Figure 4. E-cigarettes Features
Figure 5. Global Anti-Smoking Products Market Share by Application: 2020 VS 2026
Figure 6. Smokers aged 18–24 Case Studies
Figure 7. Smokers aged 25–44 Case Studies
Figure 8. Smokers aged 45–64 Case Studies
Figure 9. Smokers aged 65 years or older Case Studies
Figure 10. Anti-Smoking Products Report Years Considered
Figure 11. Global Anti-Smoking Products Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Anti-Smoking Products Market Share by Regions: 2020 VS 2026
Figure 13. Global Anti-Smoking Products Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Anti-Smoking Products Market Share by Players in 2019
Figure 16. Global Top Anti-Smoking Products Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Smoking Products as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Anti-Smoking Products Revenue in 2019
Figure 18. North America Anti-Smoking Products Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Anti-Smoking Products Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Anti-Smoking Products Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Anti-Smoking Products Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Anti-Smoking Products Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Anti-Smoking Products Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Anti-Smoking Products Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Pfizer Revenue Growth Rate in Anti-Smoking Products Business (2015-2020)
Figure 27. Cipla Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Cipla Revenue Growth Rate in Anti-Smoking Products Business (2015-2020)
Figure 29. Novartis International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Novartis International Revenue Growth Rate in Anti-Smoking Products Business (2015-2020)
Figure 31. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. GSK Revenue Growth Rate in Anti-Smoking Products Business (2015-2020)
Figure 33. Takeda pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Takeda pharmaceutical Revenue Growth Rate in Anti-Smoking Products Business (2015-2020)
Figure 35. McNeil AB Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. McNeil AB Revenue Growth Rate in Anti-Smoking Products Business (2015-2020)
Figure 37. Revolymer plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Revolymer plc Revenue Growth Rate in Anti-Smoking Products Business (2015-2020)
Figure 39. Imperial Tobacco Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Imperial Tobacco Revenue Growth Rate in Anti-Smoking Products Business (2015-2020)
Figure 41. Elder Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Elder Pharma Revenue Growth Rate in Anti-Smoking Products Business (2015-2020)
Figure 43. NJOY Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. NJOY Revenue Growth Rate in Anti-Smoking Products Business (2015-2020)
Figure 45. VMR products Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. VMR products Revenue Growth Rate in Anti-Smoking Products Business (2015-2020)
Figure 47. Lorillard Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Lorillard Revenue Growth Rate in Anti-Smoking Products Business (2015-2020)
Figure 49. VaporCorp Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. VaporCorp Revenue Growth Rate in Anti-Smoking Products Business (2015-2020)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed